StemTek Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Liquidation

StemTek Therapeutics General Information

Description

Developer novel drugs designed for cancer targeting cancer stem cells. The company is accelerating drug discovery in cancer using cutting-edge technology, world-class science, and a stem cell-centric point of view for cancer therapy, enabling physicians to treat cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • BIC BIZKAIA, Parque Tecnológico de Bizkaia
  • C/Astondo Bidea, s/n
  • 48160 Derio
  • Spain

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

StemTek Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 21-Aug-2020 Completed Bankruptcy: Liquidation
3. Accelerator/Incubator 12-Apr-2017 Completed Generating Revenue
2. Grant 12-Dec-2016 $50K Completed Generating Revenue
1. Early Stage VC 01-Jan-2016 Completed Startup
To view StemTek Therapeutics’s complete valuation and funding history, request access »

StemTek Therapeutics Patents

StemTek Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201609663-D0 Methods for producing cancer stem cell spheroids Inactive 02-Jun-2016 0000000000
US-20200283733-A1 Methods for producing cancer stem cell spheroids Inactive 02-Jun-2016 0000000000
EP-3464570-A1 Methods for producing cancer stem cell spheroids Inactive 02-Jun-2016 0000000000
CA-3026012-A1 Methods for producing cancer stem cell spheroids Inactive 02-Jun-2016 C12N5/0695

StemTek Therapeutics FAQs

  • When was StemTek Therapeutics founded?

    StemTek Therapeutics was founded in 2013.

  • Who is the founder of StemTek Therapeutics?

    Angel Martin Ph.D, Gabriel Blanco, and Olatz Esnaola Ph.D are the founders of StemTek Therapeutics.

  • Where is StemTek Therapeutics headquartered?

    StemTek Therapeutics is headquartered in Derio, Spain.

  • What industry is StemTek Therapeutics in?

    StemTek Therapeutics’s primary industry is Biotechnology.

  • Is StemTek Therapeutics a private or public company?

    StemTek Therapeutics is a Private company.

  • What is StemTek Therapeutics’s current revenue?

    The current revenue for StemTek Therapeutics is 000000.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »